We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-4.22%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$740M
AUM Growth
+$30.5M
Cap. Flow
-$239M
Cap. Flow %
-32.31%
Top 10 Hldgs %
67%
Holding
218
New
56
Increased
59
Reduced
50
Closed
36

Top Buys

Rank Stock Value
1
BTBT icon
Bit Digital
BTBT
+$40.7M
2
SLAI
SOLAI Ltd ADS
SLAI
+$15.2M
3
VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
+$7.02M
4
FLUX icon
Flux Power
FLUX
+$6.05M
5
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$5.87M

Top Sells

Rank Stock Value
1
LNAI
Lunai Bioworks
LNAI
+$7.71M
2
ATOS icon
Atossa Therapeutics
ATOS
+$4.06M
3
ATER icon
Aterian
ATER
+$4M
4
ASXC
Asensus Surgical, Inc.
ASXC
+$2.95M
5
RDHL
Redhill Biopharma
RDHL
+$2.34M

Sector Composition

Rank Sector Weight
1 Healthcare 6.89%
2 Financials 5.45%
3 Technology 3.65%
4 Industrials 1.84%
5 Communication Services 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIOT icon
51
Riot Platforms
RIOT
$8.03B
$2.08M 0.28%
81,052
+18,052
+29% +$581K
AUTL
52
Autolus Therapeutics
AUTL
$386M
$1.97M 0.27%
300,000
-100,050
-25% -$632K
TRIL
53
PUT
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.95M 0.26%
1,109
+167
+18% +$1.95K
CHRN
54
ChronoScale Holdings
CHRN
$2.94B
$1.94M 0.26%
28,012
+1,154
+4% +$81.7K
KUST
55
Kustom Entertainment Inc
KUST
$639K
$1.85M 0.25%
3
+2
+200% +$1.75M
ORIO
56
Orion Digital Corp
ORIO
$15.6M
$1.78M 0.24%
137,353
-16,070
-10% -$267K
XWEL icon
57
PUT
XWELL
XWEL
$8.87M
$1.76M 0.24%
597
+43
+8% +$1.38K
PCVX icon
58
Vaxcyte
PCVX
$7.88B
$1.69M 0.23%
66,483
-51,511
-44% -$1.25M
BCLI
59
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1.63M 0.22%
329
+15
+5% +$789
GLBS icon
60
Globus Maritime Ltd
GLBS
$60.9M
$1.63M 0.22%
556,883
-143,544
-20% -$437K
WIMI
61
WiMi Hologram Cloud
WIMI
$21M
$1.58M 0.21%
38,379
-24,231
-39% -$1.02M
BCLI
62
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1.57M 0.21%
31,755
+15,565
+96% +$819K
SPI
63
PUT
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$1.57M 0.21%
3,130
-584
-16% -$3.21K
KUST
64
PUT
Kustom Entertainment Inc
KUST
$639K
– –
0
– –
CAN
65
Canaan Creative
CAN
$178M
$1.51M 0.2%
+247,929
New +$1.93M
KNDI
66
Kandi Technologies Group
KNDI
$63.5M
$1.5M 0.2%
+337,430
New +$1.71M
NBEV
67
CALL
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$1.49M 0.2%
10,710
+597
+6% +$1.09K
OIG
68
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$1.47M 0.2%
+11,938
New +$1.66M
KRBP
69
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$1.47M 0.2%
15,937
-747
-4% -$77.3K
OCUL icon
70
Ocular Therapeutix
OCUL
$1.85B
$1.42M 0.19%
142,000
+122,783
+639% +$1.38M
ATER icon
71
PUT
Aterian
ATER
$4.21M
$1.4M 0.19%
108
-52
-33% -$5.77K
WIMI
72
PUT
WiMi Hologram Cloud
WIMI
$21M
$1.4M 0.19%
341
+47
+16% +$1.98K
PDSB icon
73
CALL
PDS Biotechnology
PDSB
$38.6M
$1.39M 0.19%
+931
New +$11.6K
INFI
74
CALL
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.32M 0.18%
3,853
+1,435
+59% +$4.42K
MTC icon
75
MMTec
MTC
$328M
$1.3M 0.18%
13,804
+1,261
+10% +$153K
1 2
3
4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q3 2021 Portfolio in Review

As of Q3 2021, Sabby Management held 218 positions worth $740M, up 4.3% from $709M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Sabby Management withdrew a net $239M in Q3 2021, closing 36 positions and reducing 50 holdings. Its most notable exit was Atossa Therapeutics, an estimated $4.06M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.9% of assets, down from 10% a quarter earlier, followed by Financials and Technology.

Against the trend, Sabby Management opened a new position in Bit Digital worth $30.5M.

  • Sabby Management's largest Q3 2021 buy was Bit Digital: 4,216,310 shares worth $30.5M.
  • Sabby Management added most to Virpax Pharmaceuticals, Inc. Common Stock in Q3 2021, an estimated $7.02M increase.
  • Sabby Management's biggest Q3 2021 reduction was Lunai Bioworks, cutting an estimated $7.71M.
  • Sabby Management fully exited Atossa Therapeutics in Q3 2021, selling an estimated $4.06M.
  • Sabby Management's ten largest holdings make up 67% of its $740M portfolio in Q3 2021.
  • Sabby Management opened 56 new positions and closed 36 in Q3 2021.
  • Sabby Management's portfolio value rose 4.3% quarter-over-quarter to $740M.

Based on Sabby Management's 13F filing for Q3 2021, filed 15 Nov 2021.